Skip to Content

WPI 2227 (Flutamide 125 mg)

This pill with imprint "WPI 2227" is Brown & White, Capsule-shape and has been identified as Flutamide 125 mg. It is supplied by Watson Pharmaceuticals, Inc..

Flutamide is used in the treatment of prostate cancer; hirsutism and belongs to the drug classes antiandrogens, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Flutamide 125 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for WPI 2227

Flutamide 125 mg WPI 2227
Flutamide 125 mg WPI 2227
Flutamide 125 mg WPI 2227
Flutamide 125 mg WPI 2227

Flutamide

Imprint:
WPI 2227
Strength:
125 mg
Color:
Brown & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiandrogens
Hormones/antineoplastics
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals, Inc.
National Drug Code (NDC):
00591-2466

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide